Authors


Ishmael Applewhite, BSN, RN-BC, OCN

Latest:

Administering CAR T-Cell Therapy and Bispecific Agents in Nursing Practice

Registered nurses discuss research related to agents like ciltacabtagene autoleucel presented at the 2024 Oncology Nursing Society Congress.


Nirav Patil, MBBS, MPH

Latest:

The Negative Impact of the COVID-19 Pandemic on Oncology Care at an Academic Cancer Referral Center

COVID-19 created unexpected delays in oncologic treatment. This study sought to assess the volume of missed cancer-related services due to the pandemic.




Vinit Makkar, MD

Latest:

Key Takeaways from the PARADIGM Study

Drs Gupta and Makkar conclude their discussion by highlighting key takeaways from the PARADIGM study and future directions that may address unmet needs in the field of la/mUC.





Basilio Pecorino, MD

Latest:

Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy

A survey was conducted in Italy for survivors of gynecologic cancer regarding quality of life, specifically that of sexual activity after a cancer diagnosis.



Trevor J. Pugh, PhD

Latest:

Trevor J. Pugh, PhD, on Reducing the Burden of Serial Testing for MMRd With 1 Sequencing Protocol

CancerNetwork® sat down with Trevor J. Pugh, PhD, to discuss a novel protocol for detecting mismatch repair deficiency.


Natasha Garg, DO, MS

Latest:

Looking Ahead in the Multiple Myeloma Treatment Landscape

Experts from City of Hope close out their panel on multiple myeloma management by identifying unmet needs and sharing what excites them in the future evolution of the treatment landscape.


Hans Kristian Nugraha, MD, SpOT

Latest:

An Arthroscopic Approach for the Intralesional Curettage of Giant Cell Tumor of the Distal Femur: A Case Report

Hans Kristian Nugraha, MD, SpOT, and colleagues detail the potential benefits of an arthroscopic surgical approach through a case study of a patient with giant cell tumor of bone.



Jill S. Barnholtz-Sloan, PhD

Latest:

The Negative Impact of the COVID-19 Pandemic on Oncology Care at an Academic Cancer Referral Center

COVID-19 created unexpected delays in oncologic treatment. This study sought to assess the volume of missed cancer-related services due to the pandemic.



Alan P. Skarbnik, MD, Novant Health Cancer Institute

Latest:

Relapsed/Refractory CLL: Key Takeaways and Ongoing Challenges

Closing out their discussion on relapsed/refractory chronic lymphocytic leukemia, key opinion leaders consider important takeaways from the indirect comparison study of acalabrutinib versus zanubrutinib and identify unmet needs in the treatment landscape.


Natasza Posielski, MD

Latest:

Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017

Patients 70 years or older that received neoadjuvant chemotherapy and radical cystectomy had better overall survival than those undergoing radical cystectomy alone.


Gina Mauro

Latest:

Perioperative Pembrolizumab Combo Improves Responses in NSCLC Subgroups

Subgroup data from KEYNOTE-671 support the use of perioperative pembrolizumab in stage II or III non–small cell lung cancer of any clinical nodal status.


Jacob D. Soumerai, MD

Latest:

CLL Workshop Emphasizes Engaging Conversations on Shared Treatment Planning

Both clinicians and patients should have as much information as possible to participate in shared decision-making for CLL care, says Jacob D. Soumerai, MD.



Hans Lee, MD

Latest:

Key Takeaways/Final Comments

Panelists discuss how 4-drug regimens anchored by CD38 antibodies are becoming the standard of care in myeloma, with future directions focusing on integrating novel immunotherapies and potentially redefining the role of transplant.





Sai-Hong Ou, MD, PhD

Latest:

Unmet Needs and Future Perspectives in NSCLC Treatment

The panelists close their discussion on non-small cell lung cancer by emphasizing the need for continued research, early screening, and collaboration with dermatologists to address the unmet needs and improve overall outcomes.


Mitchell Kamrava, MD

Latest:

Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics

Experts in the field review integration of approved PARP inhibitors into advanced prostate cancer clinical practice.


Payal Khincha, MBBS, MSHS

Latest:

Sound Biologic Foundation May Support Metformin in Li-Fraumeni Syndrome

The ability of metformin to disrupt mitochondrial metabolism may help mitigate the risk of cancer in patients with Li-Fraumeni syndrome.


Nerea M. Lopetegui-Lia, MD

Latest:

Best Practices for the Medical Oncology Boards

A group of clinicians gives study advice on how to best prepare for the medical oncology board examinations.


James Masciale, PhD

Latest:

Decisional Capacity Determination in Patients With Cancer

Experts discuss the process of assessing decision-making capacity in patients with cancer.